Schedule 13G/A
DERM Schedule 13G/A filing by Vanguard Capital Management
Vanguard Capital Management reported beneficial ownership of 774.6K shares, representing 12% of Journey Medical Corp in this filing.
FiledJul 31, 2026
Ownership dateJun 30, 2026
Reported shares774.6K
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
99.4K
Shared voting power
774.6K
Sole dispositive power
774.6K
Shared dispositive power
774.6K
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$6.37as of Jul 31, 2026
Latest tracked price$6.40as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Vanguard Capital Management
- CIK
- CIK0002100119
- Accession
- 0002100119-26-001452
- Form
- Schedule 13G/A
Read the filing in context